P/E ratio for CompuGroup Medical (COP.DE)
P/E ratio as of April 2024 (TTM): 17.1
According to CompuGroup Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.127. At the end of 2022 the company had a P/E ratio of 22.8.
P/E ratio history for CompuGroup Medical from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 22.8 | -54.55% |
| 2021 | 50.1 | -3.1% |
| 2020 | 51.7 | 10.1% |
| 2019 | 47.0 | 115.05% |
| 2018 | 21.8 | -75.65% |
| 2017 | 89.7 | 107.3% |
| 2016 | 43.3 | -1.42% |
| 2015 | 43.9 | 16.91% |
| 2014 | 37.5 | -4.61% |
| 2013 | 39.4 | 62.78% |
| 2012 | 24.2 | -47.19% |
| 2011 | 45.8 | 36.56% |
| 2010 | 33.5 | 8.02% |
| 2009 | 31.0 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.